Omega Healthcare Investors (NYSE:OHI) PT Raised to $32.00 at Truist Financial

Omega Healthcare Investors (NYSE:OHI) had its price target hoisted by equities researchers at Truist Financial from $31.00 to $32.00 in a note issued to investors on Tuesday, Benzinga reports. The brokerage currently has a “hold” rating on the real estate investment trust’s stock. Truist Financial’s target price would indicate a potential upside of 0.95% from the company’s current price.

A number of other analysts have also recently weighed in on the stock. Deutsche Bank Aktiengesellschaft assumed coverage on shares of Omega Healthcare Investors in a report on Tuesday, January 30th. They issued a “buy” rating and a $36.00 price objective on the stock. Wells Fargo & Company raised shares of Omega Healthcare Investors from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $31.00 to $35.00 in a research note on Monday, February 26th. BNP Paribas raised shares of Omega Healthcare Investors from an “underperform” rating to a “neutral” rating and set a $30.00 target price on the stock in a research note on Thursday, February 8th. Mizuho lowered their target price on shares of Omega Healthcare Investors from $35.00 to $34.00 and set a “buy” rating on the stock in a research note on Wednesday, January 3rd. Finally, Citigroup raised shares of Omega Healthcare Investors from a “neutral” rating to a “buy” rating and raised their target price for the company from $32.00 to $35.00 in a research note on Friday, March 22nd. Seven analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $33.58.

Omega Healthcare Investors Stock Performance

Shares of OHI stock traded down $0.12 during trading hours on Tuesday, reaching $31.70. The stock had a trading volume of 65,971 shares, compared to its average volume of 1,839,072. The company has a debt-to-equity ratio of 1.35, a current ratio of 6.76 and a quick ratio of 6.76. Omega Healthcare Investors has a twelve month low of $26.00 and a twelve month high of $34.77. The firm has a 50-day simple moving average of $30.51 and a 200-day simple moving average of $31.41. The firm has a market capitalization of $7.78 billion, a PE ratio of 32.08, a price-to-earnings-growth ratio of 10.43 and a beta of 0.91.

Institutional Investors Weigh In On Omega Healthcare Investors

Hedge funds have recently made changes to their positions in the company. Left Brain Wealth Management LLC grew its position in Omega Healthcare Investors by 2.0% during the 4th quarter. Left Brain Wealth Management LLC now owns 17,365 shares of the real estate investment trust’s stock worth $532,000 after purchasing an additional 335 shares in the last quarter. CreativeOne Wealth LLC raised its position in Omega Healthcare Investors by 3.9% during the second quarter. CreativeOne Wealth LLC now owns 9,530 shares of the real estate investment trust’s stock valued at $292,000 after buying an additional 356 shares during the period. Belpointe Asset Management LLC lifted its stake in Omega Healthcare Investors by 2.5% in the 1st quarter. Belpointe Asset Management LLC now owns 14,406 shares of the real estate investment trust’s stock worth $395,000 after acquiring an additional 356 shares in the last quarter. BOKF NA lifted its position in shares of Omega Healthcare Investors by 1.1% in the fourth quarter. BOKF NA now owns 35,004 shares of the real estate investment trust’s stock worth $1,073,000 after purchasing an additional 365 shares in the last quarter. Finally, Royal Fund Management LLC increased its stake in Omega Healthcare Investors by 1.0% in the 4th quarter. Royal Fund Management LLC now owns 35,656 shares of the real estate investment trust’s stock valued at $1,093,000 after buying an additional 369 shares during the period. Hedge funds and other institutional investors own 65.25% of the company’s stock.

About Omega Healthcare Investors

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.